Last Updated on December 31, 2023 by The Health Master
Zydus Cadila has received tentative approval from the US Food and Drugs Administration (USFDA) to market Adapalene and Benzoyl Peroxide Gel 0.3%/2.5%.
Adapalene and Benzoyl Peroxide combination is used to treat acne, the company notified via a statement.
It works by killing the bacteria that cause acne and by keeping the skin pores clean. The drug will be manufactured at the group’s Topical plant at Ahmedabad, it added.
The group now has 323 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04, it further said.
USFDA gives nod to Drug to treat Rare Autoimmune Disease
USFDA gives tentative nod to Lupin for generic Brexpiprazole tablets
Zydus Cadila gets USFDA nod for drug to treat Psoriasis
Zydus Cadila gets USFDA nod for Antidepressant drug
Zydus Cadila gets tentative nod from USFDA for Brexpiprazole tablets
USFDA to review use of Blood Disorder Therapy in children
Recommendation of restriction on import of IPA used by Pharma Industry
Licensing process to ASU drug manufacturers made Paperless
Dedicated chapter on Medical Devices should be included in Pharmacy Course:…
Generic medicines are cheaper as compared to branded and equally effective
USFDA gives nod to Drug to treat Rare Autoimmune Disease
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
